Financial reports
10-Q
2023 Q3
Quarterly report
9 Nov 23
10-Q
2023 Q2
Quarterly report
14 Aug 23
ARS
2022 FY
Annual report to shareholders
11 Aug 23
10-QT
Quarterly report for transitional period
5 Jun 23
10-Q
2023 Q1
Quarterly report
11 May 23
10-Q
2023 Q1
Quarterly report
14 Feb 23
10-K
2022 FY
Annual report
21 Dec 22
10-Q
2022 Q3
Quarterly report
11 Aug 22
10-Q
2022 Q2
Quarterly report
12 May 22
10-Q
2022 Q1
Quarterly report
11 Feb 22
Current reports
8-K
NeuBase Therapeutics Announces Receipt of Notice from Nasdaq
5 Apr 24
8-K
Other Events
7 Mar 24
8-K
Other Events
23 Feb 24
8-K
Entry into a Material Definitive Agreement
26 Jan 24
8-K
Departure of Directors or Certain Officers
17 Jan 24
8-K
Termination of a Material Definitive Agreement
28 Dec 23
8-K
Termination of a Material Definitive Agreement
22 Dec 23
8-K
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
6 Nov 23
8-K
Other Events
20 Oct 23
8-K
Entry into a Material Definitive Agreement
18 Oct 23
Registration and prospectus
424B3
Prospectus supplement
28 Dec 23
424B3
Prospectus supplement
10 Aug 23
S-1
IPO registration
28 Jul 23
D
Exempt offering of security
7 Jul 23
424B5
Prospectus supplement for primary offering
30 Jun 23
424B3
Prospectus supplement
30 Jun 23
S-8
Registration of securities for employees
6 Mar 23
424B5
Prospectus supplement for primary offering
29 Dec 22
S-8
Registration of securities for employees
8 Apr 22
424B5
Prospectus supplement for primary offering
27 Aug 21
Proxies
DEF 14A
Definitive proxy
9 Apr 24
PRE 14A
Preliminary proxy
25 Mar 24
DEFA14A
Additional proxy soliciting materials
18 Sep 23
DEFA14A
Additional proxy soliciting materials
11 Aug 23
DEF 14A
Definitive proxy
11 Aug 23
PRE 14A
Preliminary proxy
1 Aug 23
DEFA14A
Additional proxy soliciting materials
22 Jul 22
DEF 14A
Definitive proxy
22 Jul 22
PRE 14A
Preliminary proxy
12 Jul 22
DEFA14A
Additional proxy soliciting materials
2 Jul 21
Other
EFFECT
Notice of effectiveness
11 Aug 23
CORRESP
Correspondence with SEC
7 Aug 23
UPLOAD
Letter from SEC
3 Aug 23
UPLOAD
Letter from SEC
20 Mar 23
CORRESP
Correspondence with SEC
16 Mar 23
UPLOAD
Letter from SEC
8 Mar 23
EFFECT
Notice of effectiveness
8 Jul 21
CORRESP
Correspondence with SEC
2 Jul 21
UPLOAD
Letter from SEC
1 Jul 21
EFFECT
Notice of effectiveness
15 Apr 21
Ownership
SC 13G/A
GREENLIGHT CAPITAL INC
14 Feb 24
5
Aleta Shiff
20 Sep 23
SC 13D/A
Symetryx Corp
20 Sep 23
4
Change in insider ownership
18 Sep 23
SC 13D/A
Symetryx Corp
14 Sep 23
3/A
Aleta Shiff
12 Sep 23
4
Change in insider ownership
11 Sep 23
4
Change in insider ownership
7 Sep 23
3
Initial statement of insider ownership
1 Sep 23
SC 13D
Symetryx Corp
31 Aug 23